Adolescents and young adults using a hybrid closed-loop system were found to have better glycemic control and overall better quality of life in a new study published in JAMA Pediatrics.

Over a duration of 6 months, patients 12 to 25 years of age, with type 1 diabetes who were using a hybrid closed-loop system had a significant increase in time in target glucose range of 70 to 180 mg/dL, from 53.1% at baseline rising to 62.5% at the end of the study. Participants receiving conventional therapy, with either a continuous subcutaneous insulin infusion or multiple daily insulin injections with or without continuous glucose monitoring, had a rise from 54.6% at baseline to 56.1% at study end, with a mean adjusted difference between the study groups of 6.7% (95% CI 2.7-10.8, P=0.002)… (Medpage Today)